Conflict of Interest Waiver Details For Cmte. Members Should Be Public – BMS

FDA advisory committee members granted conflict of interest waivers should be required to disclose the companies to which they have financial ties, Bristol-Myers Squibb maintains in comments to FDA

More from Archive

More from Pink Sheet